Oventus Medical Limited
Oventus Medical Limited OVN.AX Peers
See (OVN.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OVN.AX | $0.02 | N/A | 4.83M | -0.40 | -$0.05 | N/A |
| COH.AX | $274.07 | +1.11% | 17.88B | 48.42 | $5.66 | +1.55% |
| PNV.AX | $1.38 | -4.18% | 949.91M | 137.50 | $0.01 | N/A |
| IMR.AX | $1.61 | +2.88% | 457.22M | -8.05 | -$0.20 | N/A |
| EBR.AX | $1.22 | +3.85% | 453.07M | -6.07 | -$0.20 | N/A |
| AVH.AX | $2.12 | +3.41% | 263.33M | -3.12 | -$0.68 | N/A |
| AVR.AX | $6.31 | -3.22% | 239.07M | -1.07 | -$5.87 | N/A |
| ARX.AX | $0.44 | N/A | 151.76M | -22.00 | -$0.02 | N/A |
| EMV.AX | $1.70 | -0.29% | 144.95M | -24.21 | -$0.07 | N/A |
| CYC.AX | $1.26 | +6.78% | 140.03M | -9.69 | -$0.13 | N/A |
Stock Comparison
OVN.AX vs COH.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, COH.AX has a market cap of 17.88B. Regarding current trading prices, OVN.AX is priced at $0.02, while COH.AX trades at $274.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas COH.AX's P/E ratio is 48.42. In terms of profitability, OVN.AX's ROE is -0.80%, compared to COH.AX's ROE of +0.20%. Regarding short-term risk, OVN.AX is more volatile compared to COH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs PNV.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, PNV.AX has a market cap of 949.91M. Regarding current trading prices, OVN.AX is priced at $0.02, while PNV.AX trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas PNV.AX's P/E ratio is 137.50. In terms of profitability, OVN.AX's ROE is -0.80%, compared to PNV.AX's ROE of +0.08%. Regarding short-term risk, OVN.AX is more volatile compared to PNV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs IMR.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, IMR.AX has a market cap of 457.22M. Regarding current trading prices, OVN.AX is priced at $0.02, while IMR.AX trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas IMR.AX's P/E ratio is -8.05. In terms of profitability, OVN.AX's ROE is -0.80%, compared to IMR.AX's ROE of +4.30%. Regarding short-term risk, OVN.AX is more volatile compared to IMR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs EBR.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, EBR.AX has a market cap of 453.07M. Regarding current trading prices, OVN.AX is priced at $0.02, while EBR.AX trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas EBR.AX's P/E ratio is -6.07. In terms of profitability, OVN.AX's ROE is -0.80%, compared to EBR.AX's ROE of -0.91%. Regarding short-term risk, OVN.AX is less volatile compared to EBR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs AVH.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, AVH.AX has a market cap of 263.33M. Regarding current trading prices, OVN.AX is priced at $0.02, while AVH.AX trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas AVH.AX's P/E ratio is -3.12. In terms of profitability, OVN.AX's ROE is -0.80%, compared to AVH.AX's ROE of -0.40%. Regarding short-term risk, OVN.AX is more volatile compared to AVH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs AVR.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, AVR.AX has a market cap of 239.07M. Regarding current trading prices, OVN.AX is priced at $0.02, while AVR.AX trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas AVR.AX's P/E ratio is -1.07. In terms of profitability, OVN.AX's ROE is -0.80%, compared to AVR.AX's ROE of -2.19%. Regarding short-term risk, OVN.AX is less volatile compared to AVR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs ARX.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, ARX.AX has a market cap of 151.76M. Regarding current trading prices, OVN.AX is priced at $0.02, while ARX.AX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas ARX.AX's P/E ratio is -22.00. In terms of profitability, OVN.AX's ROE is -0.80%, compared to ARX.AX's ROE of -0.08%. Regarding short-term risk, OVN.AX is more volatile compared to ARX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs EMV.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, EMV.AX has a market cap of 144.95M. Regarding current trading prices, OVN.AX is priced at $0.02, while EMV.AX trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas EMV.AX's P/E ratio is -24.21. In terms of profitability, OVN.AX's ROE is -0.80%, compared to EMV.AX's ROE of -0.36%. Regarding short-term risk, OVN.AX is more volatile compared to EMV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs CYC.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, CYC.AX has a market cap of 140.03M. Regarding current trading prices, OVN.AX is priced at $0.02, while CYC.AX trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas CYC.AX's P/E ratio is -9.69. In terms of profitability, OVN.AX's ROE is -0.80%, compared to CYC.AX's ROE of -0.29%. Regarding short-term risk, OVN.AX is less volatile compared to CYC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs 4DX.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, 4DX.AX has a market cap of 117.14M. Regarding current trading prices, OVN.AX is priced at $0.02, while 4DX.AX trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas 4DX.AX's P/E ratio is -2.36. In terms of profitability, OVN.AX's ROE is -0.80%, compared to 4DX.AX's ROE of -0.60%. Regarding short-term risk, OVN.AX is less volatile compared to 4DX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs SOM.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, SOM.AX has a market cap of 116.70M. Regarding current trading prices, OVN.AX is priced at $0.02, while SOM.AX trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas SOM.AX's P/E ratio is -10.80. In terms of profitability, OVN.AX's ROE is -0.80%, compared to SOM.AX's ROE of -0.13%. Regarding short-term risk, OVN.AX is less volatile compared to SOM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs IPD.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, IPD.AX has a market cap of 62.85M. Regarding current trading prices, OVN.AX is priced at $0.02, while IPD.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas IPD.AX's P/E ratio is -3.10. In terms of profitability, OVN.AX's ROE is -0.80%, compared to IPD.AX's ROE of -0.58%. Regarding short-term risk, OVN.AX is less volatile compared to IPD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs CMP.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, CMP.AX has a market cap of 57.67M. Regarding current trading prices, OVN.AX is priced at $0.02, while CMP.AX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas CMP.AX's P/E ratio is -15.00. In terms of profitability, OVN.AX's ROE is -0.80%, compared to CMP.AX's ROE of -0.09%. Regarding short-term risk, OVN.AX is more volatile compared to CMP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs RSH.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, RSH.AX has a market cap of 51.98M. Regarding current trading prices, OVN.AX is priced at $0.02, while RSH.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas RSH.AX's P/E ratio is -3.30. In terms of profitability, OVN.AX's ROE is -0.80%, compared to RSH.AX's ROE of -2.03%. Regarding short-term risk, OVN.AX is less volatile compared to RSH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs MX1.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, MX1.AX has a market cap of 40.03M. Regarding current trading prices, OVN.AX is priced at $0.02, while MX1.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas MX1.AX's P/E ratio is -3.00. In terms of profitability, OVN.AX's ROE is -0.80%, compared to MX1.AX's ROE of -1.06%. Regarding short-term risk, OVN.AX is more volatile compared to MX1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs EYE.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, EYE.AX has a market cap of 36.94M. Regarding current trading prices, OVN.AX is priced at $0.02, while EYE.AX trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas EYE.AX's P/E ratio is -3.25. In terms of profitability, OVN.AX's ROE is -0.80%, compared to EYE.AX's ROE of -0.44%. Regarding short-term risk, OVN.AX is less volatile compared to EYE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs CSX.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, CSX.AX has a market cap of 35.16M. Regarding current trading prices, OVN.AX is priced at $0.02, while CSX.AX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas CSX.AX's P/E ratio is -22.50. In terms of profitability, OVN.AX's ROE is -0.80%, compared to CSX.AX's ROE of -0.08%. Regarding short-term risk, OVN.AX is less volatile compared to CSX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs LBT.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, LBT.AX has a market cap of 29.89M. Regarding current trading prices, OVN.AX is priced at $0.02, while LBT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas LBT.AX's P/E ratio is -0.42. In terms of profitability, OVN.AX's ROE is -0.80%, compared to LBT.AX's ROE of -1.50%. Regarding short-term risk, OVN.AX is more volatile compared to LBT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs NTI.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, NTI.AX has a market cap of 25.19M. Regarding current trading prices, OVN.AX is priced at $0.02, while NTI.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas NTI.AX's P/E ratio is -2.40. In terms of profitability, OVN.AX's ROE is -0.80%, compared to NTI.AX's ROE of -1.34%. Regarding short-term risk, OVN.AX is more volatile compared to NTI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs CDX.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, CDX.AX has a market cap of 19.90M. Regarding current trading prices, OVN.AX is priced at $0.02, while CDX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas CDX.AX's P/E ratio is -0.82. In terms of profitability, OVN.AX's ROE is -0.80%, compared to CDX.AX's ROE of -2.72%. Regarding short-term risk, OVN.AX is less volatile compared to CDX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs OSL.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, OSL.AX has a market cap of 18.43M. Regarding current trading prices, OVN.AX is priced at $0.02, while OSL.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas OSL.AX's P/E ratio is -0.40. In terms of profitability, OVN.AX's ROE is -0.80%, compared to OSL.AX's ROE of -1.97%. Regarding short-term risk, OVN.AX is less volatile compared to OSL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs TRU.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, TRU.AX has a market cap of 14.43M. Regarding current trading prices, OVN.AX is priced at $0.02, while TRU.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas TRU.AX's P/E ratio is -2.60. In terms of profitability, OVN.AX's ROE is -0.80%, compared to TRU.AX's ROE of -0.69%. Regarding short-term risk, OVN.AX is more volatile compared to TRU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs UBI.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, UBI.AX has a market cap of 14.31M. Regarding current trading prices, OVN.AX is priced at $0.02, while UBI.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas UBI.AX's P/E ratio is -1.20. In terms of profitability, OVN.AX's ROE is -0.80%, compared to UBI.AX's ROE of -0.70%. Regarding short-term risk, OVN.AX is more volatile compared to UBI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs RNO.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, RNO.AX has a market cap of 11.47M. Regarding current trading prices, OVN.AX is priced at $0.02, while RNO.AX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas RNO.AX's P/E ratio is -1.00. In terms of profitability, OVN.AX's ROE is -0.80%, compared to RNO.AX's ROE of +15.91%. Regarding short-term risk, OVN.AX is more volatile compared to RNO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs AT1.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, AT1.AX has a market cap of 10.98M. Regarding current trading prices, OVN.AX is priced at $0.02, while AT1.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas AT1.AX's P/E ratio is -1.60. In terms of profitability, OVN.AX's ROE is -0.80%, compared to AT1.AX's ROE of -0.74%. Regarding short-term risk, OVN.AX is less volatile compared to AT1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs CBL.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, CBL.AX has a market cap of 9.72M. Regarding current trading prices, OVN.AX is priced at $0.02, while CBL.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas CBL.AX's P/E ratio is -1.10. In terms of profitability, OVN.AX's ROE is -0.80%, compared to CBL.AX's ROE of -1.09%. Regarding short-term risk, OVN.AX is more volatile compared to CBL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs HMD.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, HMD.AX has a market cap of 9.63M. Regarding current trading prices, OVN.AX is priced at $0.02, while HMD.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas HMD.AX's P/E ratio is -1.10. In terms of profitability, OVN.AX's ROE is -0.80%, compared to HMD.AX's ROE of -2.84%. Regarding short-term risk, OVN.AX is less volatile compared to HMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs ADR.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, ADR.AX has a market cap of 6.07M. Regarding current trading prices, OVN.AX is priced at $0.02, while ADR.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas ADR.AX's P/E ratio is -0.17. In terms of profitability, OVN.AX's ROE is -0.80%, compared to ADR.AX's ROE of -2.87%. Regarding short-term risk, OVN.AX is more volatile compared to ADR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs IRX.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, IRX.AX has a market cap of 5.76M. Regarding current trading prices, OVN.AX is priced at $0.02, while IRX.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas IRX.AX's P/E ratio is -2.70. In terms of profitability, OVN.AX's ROE is -0.80%, compared to IRX.AX's ROE of +17.09%. Regarding short-term risk, OVN.AX is less volatile compared to IRX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs UCM.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, UCM.AX has a market cap of 5.51M. Regarding current trading prices, OVN.AX is priced at $0.02, while UCM.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas UCM.AX's P/E ratio is -2.20. In terms of profitability, OVN.AX's ROE is -0.80%, compared to UCM.AX's ROE of -0.96%. Regarding short-term risk, OVN.AX is more volatile compared to UCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs ALT.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, ALT.AX has a market cap of 4.61M. Regarding current trading prices, OVN.AX is priced at $0.02, while ALT.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas ALT.AX's P/E ratio is N/A. In terms of profitability, OVN.AX's ROE is -0.80%, compared to ALT.AX's ROE of -2.31%. Regarding short-term risk, OVN.AX is more volatile compared to ALT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs VTI.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, VTI.AX has a market cap of 3.70M. Regarding current trading prices, OVN.AX is priced at $0.02, while VTI.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas VTI.AX's P/E ratio is -0.55. In terms of profitability, OVN.AX's ROE is -0.80%, compared to VTI.AX's ROE of -0.43%. Regarding short-term risk, OVN.AX is more volatile compared to VTI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OVN.AX.
OVN.AX vs AMT.AX Comparison
OVN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OVN.AX stands at 4.83M. In comparison, AMT.AX has a market cap of 3.47M. Regarding current trading prices, OVN.AX is priced at $0.02, while AMT.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OVN.AX currently has a P/E ratio of -0.40, whereas AMT.AX's P/E ratio is -1.45. In terms of profitability, OVN.AX's ROE is -0.80%, compared to AMT.AX's ROE of -11.52%. Regarding short-term risk, OVN.AX is less volatile compared to AMT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for OVN.AX.